ALKERMES reported 58.36M in Cost of Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4142M 121M
Acadia Pharmaceuticals ACAD:US $ 2.67M 0.28M
Acorda Therapeutics ACOR:US $ 8.8M 2.83M
Amgen AMGN:US $ 1510M 51M
Biogen BIIB:US $ 484M 269.9M
Biomarin Pharmaceutical BMRN:US $ 123.13M 6.16M
Bluebird Bio BLUE:US $ 1.74M 6.56M
Bristol Myers Squibb BMY:US $ 2677M 206M
Coherus Biosciences CHRS:US $ 11.28M 1.91M
Eli Lilly And LLY:US $ 1430.5M 641.6M
Gilead Sciences GILD:US $ 1442M 18M
Heron Therapeutics HRTX:US $ 16.18M 4.82M
Horizon Pharma HZNP:US $ 230.22M 15.15M
Intra Cellular Therapies ITCI:US $ 4.65M 1.5M
IONIS PHARMACEUT IONS:US $ 4.74M 0.57M
JAZZ PHA JAZZ:US $ 124.21M 8.92M
Johnson & Johnson JNJ:US $ 7919M 321M
Merk MRK:US $ 3698M 1636M
Nektar Therapeutics NKTR:US $ 5.12M 0.2M
Neurocrine Biosciences NBIX:US $ 4.8M 0.2M
Otsuka Holdings 4578:JP Y 147947M 21607M
Pfizer PFE:US $ 8671M 1339M
Regeneron Pharmaceuticals REGN:US $ 297.1M 107.8M
Revance Therapeutics RVNC:US $ 9.52M 1.63M
Teva Pharmaceutical Industries TEVA:US $ 1958M 99M
Vertex Pharmaceuticals VRTX:US $ 261.8M 16M